212
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Development, optimization, and validation of an in-house Dot-ELISA rapid test based on SAG1 and GRA7 proteins for serological detection of Toxoplasma gondii infections

, , , , &
Pages 2657-2669 | Published online: 27 Aug 2019

References

  • Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. New York: Boca Raton; 2010:1–313.
  • Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12–13):1217–1258.11113252
  • Montoya J, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–1976. doi:10.1016/S0140-6736(04)16412-X15194258
  • Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8(1):292. doi:10.1186/s13071-015-0902-626017718
  • Aubert D, Maine GT, Villena I, et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol. 2000;38:1144–1150.10699010
  • Beghetto E, Spadoni A, Bruno L, Buffolano W, Gargano N. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol. 2006;44:2133–2140. doi:10.1128/JCM.00390-0616757610
  • Pfrepper KI, Enders G, Gohl M, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol. 2008;12:977–982.
  • Costa JG, Vilarino MJ. Antigens to detect the acute phase of toxoplasmosis in pregnant women: standardized comparison. Biomark Med. 2018;12(5):517–534.
  • Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS. 2010;118:529–542. doi:10.1111/j.1600-0463.2010.02655.x20666734
  • Holec-Gasior L. Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vac Immunol. 2013;20(9):1343–1351. doi:10.1128/CVI.00117-13
  • Kasper LH, Bradley MS, Pfefferkorn ER. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies. J Immunol. 1984;132:443.6197455
  • Jacobs D, Vercammen M, Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol. 1999;6:24–29.9874659
  • Gamble HR, Andrews CD, Dubey JP, Webert DW, Parmley SF. Use of recombinant antigens for detection of Toxoplasma gondii infection in swine. J Parasitol. 2000;86:459–462. doi:10.1645/0022-3395(2000)086[0459:UORAFD]2.0.CO;210864240
  • Revello MG, Gerna G. Human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15:680–715. doi:10.1128/CMR.15.4.680-715.200212364375
  • Pappas MG, Lunde MN, Hajkowski R, McMahon J. Determination of IgM and IgG antibodies to Toxoplasma using the IFA test, ELISA, and Dot-ELISA procedures. Vet Parasitol. 1986;20:31–42. doi:10.1016/0304-4017(86)90090-73518215
  • Pappas MG, Hajkowski R, Hockmeyer WT. Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis. J Microbiol Methods. 1983;64:205–214.
  • Gupta A, Dixit AK, Dixit P. Dot-ELISA in the diagnosis of parasitic diseases of animals. J Parasit Dis. 2008;32(1):10–14.
  • Azami SJ, Keshavarz H, Rezaian M, Mohebali M, Shojaee S. Rapid detection of Toxoplasma gondii antigen in experimentally infected mice by dot—ELISA. Iranian J Parasitol. 2011;6:28–33.
  • Teimouri A, Modarressi MH, Shojaee S, et al. Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA. Eur J Clin Microbiol Infect Dis. 2018. doi:10.1007/s10096-018-3266-y
  • Lebech M, Joynson DH, Seitz HM, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European research network on congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996;15:799–805.8950557
  • Selseleh M, Keshavarz H, Mohebali M, Shojaee S, Modarressi MH, Eshragian M. Production and evaluation of Toxoplasma gondii recombinant surface antigen 1 (SAG1) for serodiagnosis of acute and chronic Toxoplasma infection in human sera. Iranian J Parasitol. 2012;7:1–9.
  • Selseleh M, Keshavarz H, Mohebali M, et al. Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. Korean J Parasitol. 2012;50(3):233–238. doi:10.3347/kjp.2012.50.3.23322949752
  • Burgess RR. Refolding solubilized inclusion body proteins. Methods Enzymol. 2009;17:259–282.
  • Cabrita LD, Bottomley SP. Protein expression and refolding—a practical guide to getting the most out of inclusion bodies. Biotechnol Annu Rev. 2004;10:31–54.15504702
  • Teimouri A, Azami SJ, Keshavarz H, et al. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine. 2018;13:1341–1351. doi:10.2147/IJN.S17762729563791
  • Hawkes R, Niday E, Gordon J. A Dot-Immunobinding assay for monoclonal and other antibodies. Anal Biochem. 1982;119(1):142–147.7072935
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi:10.2307/2529310843571
  • Jacobson RH. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech. 1998;17(2):469–526. doi:10.20506/rst.17.2.11199713892
  • Dard C, Fricker-Hidalgo H, Brenier-Pinchart MP, Pelloux H. Relevance of and new developments in serology for toxoplasmosis. Trends Parasitol. 2016;32:492–506. doi:10.1016/j.pt.2016.04.00127167666
  • Sonaimuthu P, Fong MY, Kalyanasundaram R, Mahmud R, Lau YL. Serodiagnostic evaluation of Toxoplasma gondii recombinant Rhoptry antigen 8 expressed in E. coli. Parasit Vectors. 2014;7:297. doi:10.1186/1756-3305-7-2324986686
  • El-Masry S, El-Kady I, Zaghloul MH, Al-Badrawey MK. Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA. Clin Biochem. 2008;41:145–151. doi:10.1016/j.clinbiochem.2008.04.01118082139
  • Blanco RM, Takei K, Romero EC. Leptospiral glycolipo protein as a candidate antigen for serodiagnosis of human leptospirosis. Lett Appl Microbiol. 2009;49:267–273. doi:10.1111/j.1472-765X.2009.02665.x19496929
  • Coelho JS, Soares IS, Lemos EA, et al. A multianalyte Dot-ELISA for simultaneous detection of malaria, Chagas disease, and syphilis-specific IgG antibodies. Diagn Microbiol Infect Dis. 2007;58:223–230. doi:10.1016/j.diagmicrobio.2006.12.01117300910
  • Cai SF, Li WG, Wang M. Detection of specific IgG in the sera of patients with chronic Schistosomiasis japonica by dot-ELISA with the recombinant Sj26-Sj32 fusion protein. Chin J Parasitol Parasit Dis. 2011;29:21–24.
  • Pina R, Gutierrez AH, Gilman RH, et al. A dot-ELISA using a partially purified cathepsin-L-like protein fraction from Taenia solium cysticerci, for the diagnosis of human neurocysticercosis. Ann Trop Med Parasitol. 2011;105:311–318. doi:10.1179/136485911X1298767664978221871167
  • Sedaghat F, Sadjjadi SM, Hosseini SV, Kazemian S, Sarkari B. Evaluation of a simple Dot-ELISA in comparison with counter current immunoelectrophoresis for diagnosis of human hydatidosis. Clin Lab. 2011;57:201–205.21500727
  • Bojanich MV, Marino GL, Lopez MA, Alonso JM. An evaluation of the dot-ELISA procedure as a diagnostic test in an area with a high prevalence of human Toxocara canis infection. Mem Inst Oswaldo Cruz. 2012;107:194–197. doi:10.1590/S0074-0276201200020000722415257
  • Yunuen Cervantes-Landína A, Martínez-Martínez I, Reyes PA, Shabibc M, Espinoza Gutiérrez B. Estandarización de la técnica Dot-ELISA para la detección de anticuerpos anti-Trypanosoma cruzi y su comparación con ELISA y Western blot. Enferm Infecc Microbiol Clin. 2014;32:363–368.23890693
  • Harning D, Spenter J, Metsis A. Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin Diagn Lab Immunol. 1996;3(3):355–357.8705683
  • Quail MA. DNA Cloning. Encyclopedia of Life Sciences. New York: John Willey and Sons Ltd; 2010. doi:10.1038/npg.els.0005344
  • Khan AM, Miotto O, Heiny A, et al. A systematic bioinformatics approach for selection of epitope-based vaccine targets. Cell Immunol. 2006;244:141–147. doi:10.1016/j.cellimm.2007.02.00517434154
  • Burg JL, Perelman D, Kasper LH, Ware PL, Boothroyd JC. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988;141:3584–3591.3183382
  • Cesbron-Delauw MF, Tomavo S, Beauchamps P, et al. Similarities between the primary structures of two distinct major surface proteins of Toxoplasma gondii. J Biol Chem. 1994;26:16217–16222.
  • Idicula-Thomas S, Balaji PV. Understanding the relationship between the primary structure of proteins and its propensity to be soluble on over expression in Escherichia coli. Protein Sci. 2005;14:582–592.15689506
  • Rosano GL, Ceccarelli EA. Rare codon content affects the solubility of recombinant proteins in a codon bias-adjusted Escherichia coli strain. Microb Cell Fact. 2009;24:8–41.
  • Lilie H, Schwarz E, Rudolph R. Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol. 1998;9:497–501. doi:10.1016/S0958-1669(98)80035-99821278
  • Wu K, Chen XG, Li H, et al. Diagnosis of human toxoplasmosis by using the recombinant truncated surface antigen 1 of Toxoplasma gondii. Diagn Microbial Infect Dis. 2009;64:261–266. doi:10.1016/j.diagmicrobio.2009.02.009
  • Pietkiewicz H, Hiszczyn ska-Sawicka E, Kur J, et al. Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol. 2004;42:1779–1781. doi:10.1128/JCM.42.4.1779-1781.200415071048
  • Jacobs D, Dubremetz JF, Loyens A, Bosman F, Saman E. Identification and heterologous expression of a new dense granule protein (GRA7) from Toxoplasma gondii. Mol Biochem Parasitol. 1998;91:237–249.9566517
  • Nigro M, Gutierrez A, Hoffer AM, et al. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn Microbiol Infect Dis. 2003;47:609–613. doi:10.1016/S0732-8893(03)00156-114711483
  • Kotresha D, Poonam D, Muhammad Hafiznur Y, et al. Recombinant proteins from new constructs of SAG1 and GRA7 sequences and their usefulness to detect acute toxoplasmosis. Trop Biomed. 2012;29:129–137.22543613
  • Fischer HG, Stachelhaus S, Sahm M, Meyer HE, Reichmann G. GRA7, an excretory 29 kDa Toxoplasma gondii dense granule antigen released by infected host cells. Mol Biochem Parasitol. 1998;91:251–262.9566518
  • Neudeck A, Stachelhaus S, Nischik N, Striepen B, Reichmann G, Fischer HG. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect. 2002;4:581–590. doi:10.1016/S1286-4579(02)01576-912048027
  • Tenter AM, Johnson AM. Recognition of recombinant Toxoplasma gondii antigens by human sera in an ELISA. Parasitol Res. 1991;77:197–203. doi:10.1007/BF09308582047367
  • Johnson AM, Roberts H, Tenter AM. Evaluation of a recombinant antigen ELISA for the diagnosis of acute toxoplasmosis and comparison with traditional antigen ELISAs. J Med Microbiol. 1992;37:404–409. doi:10.1099/00222615-37-6-4041460660
  • Li S, Galvan G, Araujo FG, Suzuki Y, Remington JS, Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin Diagn Lab Immunol. 2000;7:781–787.10973455
  • Gondim L, Mineo JR, Schares G. Importance of serological cross-reactivity among Toxoplasma gondii, Hammondia spp., Neospora spp., Sarcocystis spp. and Besnoitia besnoiti. Parasitology. 2017;144(7):851–868. doi:10.1017/S003118201700006328241894
  • Lyashchenko KP, Singh M, Colangeli R, Gennaro ML. A multi-antigen print immunoassay for the development of serological diagnosis of infectious diseases. J Immunol Methods. 2000;242:91–100.10986392
  • Costa JG, Vilarino MJ. Semi quantitative Dot Blot with the GRA8 antigen to differentiate the stages of toxoplasmosis infection. J Microbiol Methods. 2018;149:9–13. doi:10.1016/j.mimet.2018.04.01529684398